Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04888195
Other study ID # SC_Blood_cancer
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2021
Est. completion date September 1, 2024

Study information

Verified date April 2022
Source The Hong Kong Polytechnic University
Contact Ka Yan Ho, PhD
Phone 27666417
Email kyeva.ho@polyu.edu.hk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pediatric blood cancer is the most common childhood malignancy. Despite its survival has been substantially improved, children still have to pay a high price for numerous distressing symptoms resulted from chemotherapy. Previous studies related to symptom experiences mainly focus on individual symptoms, rather than on multiple symptoms. Understanding these distressing symptoms may help healthcare professionals to develop appropriate and effective interventions with the aims of alleviating symptom severity and thus promoting the child's psychosocial well-being and quality of life.


Description:

A longitudinal study design will be conducted. A sample of 120 patients age 5-17years, diagnosed with blood cancer but not yet receive any chemotherapy and able to communicate with Cantonese and read Chinese will be recruited in the pediatric oncology ward of Hong Kong Children's Hospital.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date September 1, 2024
Est. primary completion date September 1, 2024
Accepts healthy volunteers No
Gender All
Age group 5 Years to 17 Years
Eligibility Inclusion Criteria: - aged 5 - 17 years old - diagnosed with blood cancer but not yet receive any chemotherapy - able to communicate with Cantonese and read Chinese Exclusion Criteria: - who are scheduled to have concurrent cancer treatment - with recurrent malignancy - medical condition, or cognitive and learning problems in their medical records

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaire
Participants will complete a set of validated questionnaires (TRSC-C and demographic sheet) before chemotherapy. They also have to complete the same questionnaires (TRSC-C) again within 1 week after the 1st, 2nd, 3rd, 4th , 5th and 6th courses of chemotherapy via telephone interview by our research assistants.

Locations

Country Name City State
Hong Kong Ka Yan Ho Hong Kong Hong Kong,China

Sponsors (1)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary The therapy-related symptom checklist for children (TRSC-C) For measuring the occurrence and severity of symptoms experienced by patients aged 5-17 when they undergo cancer treatment. Before chemotherapy
Primary The therapy-related symptom checklist for children (TRSC-C) at 1-week For measuring the occurrence and severity of symptoms experienced by patients aged 5-17 when they undergo cancer treatment. At 1-week follow-up
Primary The therapy-related symptom checklist for children (TRSC-C) at 1-month For measuring the occurrence and severity of symptoms experienced by patients aged 5-17 when they undergo cancer treatment. At 1-month follow-up
Primary The therapy-related symptom checklist for children (TRSC-C) at 3-month For measuring the occurrence and severity of symptoms experienced by patients aged 5-17 when they undergo cancer treatment. At 3-month follow-up
Primary The therapy-related symptom checklist for children (TRSC-C) at 6-month For measuring the occurrence and severity of symptoms experienced by patients aged 5-17 when they undergo cancer treatment. At 6-month follow-up
Primary Demographic sheet collect the background information of our subjects, including their age, gender, educational attainment, parents' marital status and religious belief At baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06320626 - Pharmacokinetic-guided Dosing of Emicizumab Phase 4
Completed NCT04011852 - The Role of Chest Electrical Impedance Tomography in the Pediatric Ventilator Weaning
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Recruiting NCT05016271 - Health Benefits of Air Purifiers in Primary School Students N/A
Completed NCT02551978 - Kids Obesity Prevention Program - Study (KOP) N/A
Completed NCT02240368 - Performance Evaluation of the Depth of Anesthesia Monitors in Pediatric Surgery
Completed NCT03946137 - Chest Therapy and Postural Education in Children With Cerebral Palsy N/A
Completed NCT01918020 - Impact Study of Minnesota SNAP-Ed Health and Nutrition Education Programs N/A
Completed NCT01267097 - The PAC Study: Parents as Agents of Change in Pediatric Weight Management N/A
Recruiting NCT04022460 - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed NCT05538039 - Reducing Anxiety of Children and Their Parents in the Pre-elective Surgery Process N/A
Completed NCT03156465 - Iowa Cochlear Implant Clinical Research Center Hybrid L24 and Standard Cochlear Implants in Profoundly Deaf Infants N/A
Not yet recruiting NCT05914324 - Outpatient Pediatric Pulse Oximeters in Africa N/A
Not yet recruiting NCT04827108 - Psychometric Properties of the Chinese Version of PeNAT
Not yet recruiting NCT04853303 - VR to Improve CINV, Sleep and Pain Among Children With Cancer in HK N/A
Completed NCT05374902 - Efficacy of Animation, Buzzy, and Multiple Interventions on Pain in Children N/A
Completed NCT04665453 - Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children N/A
Completed NCT04082247 - Healthy Children 2021 Study in Childcare Centers N/A
Completed NCT02858531 - Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics
Terminated NCT04009031 - Video Game for Home-based Rehabilitation for Children With Hemiplegia N/A